Press Releases
Polyplus-transfection announces the appointment of ten additional biologists and chemists to support multiple pre-clinical studies
Strasbourg, France, September 15, 2011 - Polyplus-transfection SA, which specializes in the development of innovative solutions for the delivery of nucleic acids in research and...
Press Releases
Less Than Half of Cancer Patients Informed of Fertility Preservation Options
Kim Kincaid had just met with her doctor to start planning a family when she received devastating news that same week — the 37-year-old...
Press Releases
Pfizer Extends Subsequent Offering Period of Tender Offer to Acquire Icagen, Inc.
Pfizer Inc. and Icagen, Inc. announced today that Pfizer’s wholly-owned subsidiary, Eclipse Acquisition Corp., has extended the expiration date of the subsequent offering period...
Press Releases
Mayo Clinic Teams with Glowing Cats Against AIDS, Other Diseases
Mayo Clinic researchers have developed a genome-based immunization strategy to fight feline AIDS and illuminate ways to combat human HIV/AIDS and other diseases. The...
Press Releases
Exelixis Announces Webcasts of Upcoming Investor Conference Presentations Exelixis Inc.
Exelixis, Inc. announced today that Michael Morrissey, PhD, the company’s president and chief executive officer, will present at two upcoming investor conferences. ...
Press Releases
Sucampo and Numab Sign Drug Discovery Collaboration Sucampo Pharmaceuticals Inc. and Numab AG
Sucampo Pharmaceuticals, Inc. an international pharmaceutical company, and Numab AG today announced that Sucampo’s wholly owned subsidiary, Sucampo AG, and Numab AG, have entered...
Press Releases
Trophos completes patient enrolment in pivotal efficacy study of olesoxime in Spinal Muscular Atrophy
Marseille France, September 8, 2011 - Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.